ÂÜÀòÂÒÂ×

Birgitta Grundmark is a Medical Doctor and Researcher who has extensive experience in pharmacovigilance, signal detection, and oncology. Birgitta has held various positions at companies such as Uppsala Monitoring Centre, European Medicines Agency, and WHO-UMC network, focusing on assessing and validating safety signals of adverse drug reactions. With a background in oncology and clinical pharmacology, Birgitta has made significant contributions to the field of drug development and patient safety. Birgitta holds a Medical degree from Uppsala University and has a strong educational background in natural sciences.